|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT00301288 |
|
Date of registration:
|
09/03/2006 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Non-Hodgkin Lymphoma (NHL).
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
June 2002 |
|
Target sample size:
|
152 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00301288 |
|
Study type:
|
Observational |
|
Study design:
|
Time Perspective: Retrospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
United Kingdom
| | | | | | | |
|
Contacts
|
|
Name:
|
David Cunningham, FRCP |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Royal Marsden NHS Foundation Trust |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- a) Age over 18 b) Patients with Non-Hodgkin's Lymphoma who have received an autologous
stem cell transplant in the past.
c) Informed written consent
Exclusion Criteria:
- a) Medical or psychiatric conditions that compromise the patient's ability to give
informed consent b) HIV positive or AIDS related lymphoma
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Non-Hodgkins Lymphoma
|
|
Intervention(s)
|
|
Procedure: Autologous stem cell transplant
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|